readthroughSign in
CompanyWHWKNasdaqMorristown, NJ

Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics develops antibody-drug conjugates for oncology, including HWK-007, HWK-016, and HWK-206 in clinical development.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 12Latest story